Business & Regulation

For any organization, one ill-timed tweet can create enormous backlash.

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

Sitting Down With… Gen Li, CEO, Phesi

A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?

Can AI realistically transform data management in pharma? Yes. And it’s already begun.

What did switching from client to constructor teach a seasoned biotech professional?

Fake tweet announcing free insulin leads to mayhem.

How a new working group plans to overcome the problem with in vitro pharmacology data.

Unregulated drugs being sold and distributed by the online retailer come under fire.